For more detailed information regarding side effects, please refer to the appropriate product monograph.
Infusion-related reactions – sometimes can be managed with pre-medications, IV fluids, or lengthening infusion duration.
Increased risk of serious infection (sepsis and pneumonia), invasive fungal infections and viral infections; approximately 10% increased risk at wk 54. Reactivation of latent TB.
Can worsen pre-existing CHF.
Lupus-like reaction (rare).
Anti-TNF–induced psoriasis and eczema.
Hepatocellular damage, hepatitis, jaundice, autoimmune hepatitis; reactivation of HBV.
Potential increased risk of malignancy (lymphoma, hepatosplenic T-cell lymphoma, melanoma, and NMSC); increased frequency when used in combination with a thiopurine.
Demyelinating disease – numbness and tingling in legs, arms, etc.
Change in vision, weakness in legs, dizziness.
Edit Content
SIDE EFFECTS
For more detailed information regarding side effects, please refer to the appropriate product monograph.
Infusion-related reactions – sometimes can be managed with pre-medications, IV fluids, or lengthening infusion duration.
Increased risk of serious infection (sepsis and pneumonia), invasive fungal infections and viral infections; approximately 10% increased risk at wk 54. Reactivation of latent TB.
Can worsen pre-existing CHF.
Lupus-like reaction (rare).
Anti-TNF–induced psoriasis and eczema.
Hepatocellular damage, hepatitis, jaundice, autoimmune hepatitis; reactivation of HBV.
Potential increased risk of malignancy (lymphoma, hepatosplenic T-cell lymphoma, melanoma, and NMSC); increased frequency when used in combination with a thiopurine.
Demyelinating disease – numbness and tingling in legs, arms, etc.
Change in vision, weakness in legs, dizziness.
Edit Content
SIDE EFFECTS
For more detailed information regarding side effects, please refer to the appropriate product monograph.
Injection-site reactions
Headaches
Diarrhea
Skin rash or itching
Possible infusion reaction
Edit Content
SIDE EFFECTS
For more detailed information regarding side effects, please refer to the appropriate product monograph.
Nasopharyngitis
Arthralgia
Headache
Nausea
Pyrexia
Upper respiratory tract infection
Fatigue
Malignancy
Elevated transaminase has been reported
No serious infections
Edit Content
SIDE EFFECTS
For more detailed information regarding side effects, please refer to the appropriate product monograph.
Fatigue
Upper respiratory infections
Headache
Arthralgia
Injection-site reaction
Elevated liver enzymes reported during induction
Edit Content
SIDE EFFECTS
For more detailed information regarding side effects, please refer to the appropriate product monograph.
CANIBD and Crohn's and Colitis Canada do not accept any responsibility or liability for the accuracy, content, completeness, legality, or reliability of the information contained in this Service. The content is not intended to diagnose, treat, cure or prevent disease. Content was developed in 2024 and is provided for informational purposes only.